Jennifer A. Webb

Articles

Hand-held optical coherence tomography device cleared for marketing

The FDA has cleared for marketing a hand-held spectral-domain ophthalmic imaging system that opens new doors to ophthalmologists to diagnose eye disease in infants, children, and disabled adults.

All eyes on Capitol Hill

A record number of ophthalmologists hit the hallways on Capitol Hill last month to urge their legislators to protect Americans' access to eye care and boost funding for eye research.

Use genetic testing with caution

Ophthalmologists should not order routine genetic tests for patients with common disorders like age-related macular degeneration until there are specific therapeutic interventions available to treat the disease based on the genetic information.

ARVO moves its annual meeting from Fort Lauderdale

May 01, 2012

Having the ARVO meeting in any of various locations enables the group to accommodate more program options and have a variety of hotel options nearby.

More supplies of counterfeit drug found

May 01, 2012

FDA investigators say counterfeit vials of Roche/Genentech's bevacizumab that have turned up in U.S. medical practices for the second time in 2 months have no active ingredient.

Valeant acquires Eyetech

March 01, 2012

Six years after OSI Pharmaceuticals Inc. bought Eyetech Pharmaceuticals Inc. for $650 million on the promise of its treatment for wet age-related macular degeneration, Valeant Pharmaceuticals International Inc. has announced it will acquire Eyetech for $22 million.